- Q1 2024 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 08, 2024€9.94Earnings
- Q4 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptFeb 28, 2024€4.89 (+1.45%)Earnings
- Mind Medicine (MindMed) Inc to Host Conference Call TranscriptDec 14, 2023
- Q3 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 02, 2023€2.52 (+8.91%)Earnings
- Mind Medicine (MindMed) Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Q2 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 03, 2023€4.26 (-3.22%)Earnings
- Mind Medicine (MindMed) Inc at H.C. Wainwright Neuropsychiatry Virtual Conference TranscriptJun 26, 2023
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Q1 2023 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 04, 2023€3.24 (-2.59%)Earnings
- Mind Medicine (MindMed) Inc at ROTH Conference TranscriptMar 13, 2023
- Mind Medicine (MindMed) Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q4 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 09, 2023€3.1 (-1.59%)Earnings
- Mind Medicine (MindMed) Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Mind Medicine (MindMed) Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptNov 10, 2022€2.43 (-2.80%)Earnings
- Q2 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 11, 2022€9.51 (+3.09%)Earnings
- Mind Medicine (MindMed) Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Mind Medicine (MindMed) Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- Q1 2022 Mind Medicine (MindMed) Inc Earnings Call TranscriptMay 16, 2022€11.84 (+6.96%)Earnings
- Q4 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptMar 28, 2022€16.13 (-0.42%)Earnings
- Q2 2021 Mind Medicine (MindMed) Inc Earnings Call TranscriptAug 16, 2021Earnings
Mind Medicine (MindMed) Inc to Host Conference Call Transcript
Fair enough, no, and and good morning, and welcome to the MIND medicine conference call announcing top line preliminary results from the Company's Phase IIb study of MM. one 20 in generalized anxiety disorder.
Currently, all participants are in a listen only mode. This call is being webcast live on the Investors and Media section of mine mix website at Mine met.com and the recording will be available after the call.
For opening remarks, I would like to introduce SEAN Greenway, CFO of mine met. Please go ahead.
()-
Hello, and thank you for joining us on today's conference call to discuss top-line results for our Phase IIb study of evident one 20 in patients with generalized anxiety disorder. Our press release describing the results of this study was issued today and is available in the News and Events section in the Investors section of our website. Today's presentation will also be available in the Presentations section in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)